Investors focused on the Medical space have likely heard of Bausch Health Cos (BHC - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? One simple way to answer this question is to take a look at the year-to-date performance of BHC and the rest of the Medical group's stocks.
Bausch Health Cos is one of 843 companies in the Medical group. The Medical group currently sits at #3 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. BHC is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past three months, the Zacks Consensus Estimate for BHC's full-year earnings has moved 10.37% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
According to our latest data, BHC has moved about 11.21% on a year-to-date basis. In comparison, Medical companies have returned an average of 0.81%. This means that Bausch Health Cos is outperforming the sector as a whole this year.
To break things down more, BHC belongs to the Medical - Generic Drugs industry, a group that includes 24 individual companies and currently sits at #57 in the Zacks Industry Rank. On average, this group has lost an average of 7.48% so far this year, meaning that BHC is performing better in terms of year-to-date returns.
Investors in the Medical sector will want to keep a close eye on BHC as it attempts to continue its solid performance.